4 key points on aspirin continuation during spinal surgery

Written by Laura Dyrda | August 22, 2017 | Print  |

A new study published in The Spine Journal examines risks of aspirin continuation during spinal procedures.

 

The study authors examined 1,339 studies and included three case studies in the meta-analysis that compared aspirin continuation with aspirin discontinuation during spinal procedures. The study authors found:

 

1. The studies included similar operative times between the patients who continued aspirin and patients who didn't. Patients who continued aspirin reported average operating time of 201.8 minutes, compared to 178.4 minutes for the aspirin-discontinuing group.

 

2. Both groups reported similar blood loss; average blood loss in the aspiring-continuing group was 553.7 mL, compared to 538.7 mL among the aspirin discontinuing group.

 

3. Both groups reported similar levels of cardiac events, stroke and surgical site infection.

 

4. The study authors found an "absence of significant difference in peri-operative complications between aspirin continuation and discontinuation" but recommended further studies to demonstrate the potential benefit and safety.

 

More articles on spine surgery:
5 trends in orthopedic, spine adverse events
4 spine surgeons offer tips for future leaders
Artificial disc replacement after cervical fusion?

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months